Noveris Health Sciences Inc. (MYCOF)
Sector: Medical - Pharmaceuticals
Industry: Medical - Pharmaceuticals
Noveris Health Sciences Inc.
OTC:MYCOFHealthcare · Medical - Pharmaceuticals
Mkt Cap-
EV-
Float54.67M
O/S58.55M
Inst Own-
Net Cash/Sh-
Dilution
MCap-Float54.67MO/S58.55M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 0.7300 | 0.8000 | 0.7300 | 0.7300 | 1,000 |
| Nov 13, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 12, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 11, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 10, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 9, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 6, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 5, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 4, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Nov 3, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 30, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 29, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 28, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 27, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 26, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 23, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 21, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 20, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 19, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
| Oct 16, 2026 | 0.7300 | 0.7300 | 0.7300 | 0.7300 | 1,000 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 58.55M shares outstanding
SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeOTC
Country
CA
IPO Date-
Shares Outstanding58.55M
Authorized Shares
Float54.67M
52-Week Range
Volume
Average Daily Volume--
30d Avg
--
60d Avg
--
90d Avg
--
Earnings
Dividend History
No dividend history available